The authors work in the department of Infectious
diseases, Infection control and employee Health
at the University of Texas M.D. Anderson cancer
center in Houston. Bena Ellickalputhenpura is a
PA and Harrys Torres is an assistant professor of medicine.
No relationships to disclose.
Disclosure: Dr. Torres is a consultant for Merck & Co, Inc; Novartis; Astellas; Pharma US, Inc; Pfizer Inc; and Vertex Pharmaceuticals Inc and has received research grants from Merck & Co.